Cargando…

Survival of bladder or renal cancer in patients with CHEK2 mutations

PURPOSE: The purpose of this study was to compare the clinical characteristics and the survival of CHEK2 mutation positive and CHEK2 mutation negative patients diagnosed with bladder or kidney cancer. MATERIALS AND METHODS: 1016 patients with bladder and 402 cases with kidney cancer and 8302 control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Złowocka-Perłowska, Elżbieta, Dębniak, Tadeusz, Słojewski, Marcin, van de Wetering, Thierry, Tołoczko-Grabarek, Aleksandra, Cybulski, Cezary, Scott, Rodney J., Lubiński, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428549/ https://www.ncbi.nlm.nih.gov/pubmed/34499690 http://dx.doi.org/10.1371/journal.pone.0257132

Ejemplares similares

Bladder cancer survival in patients with NOD2 or CDKN2A variants
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2021)

Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Selenium and risk of bladder cancer
por: Złowocka-Perłowska, E, et al.
Publicado: (2012)

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor
por: Ogrodniczak, Alicja, et al.
Publicado: (2022)

Smoking Related Cancers and Loci at Chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish Population
por: Jaworowska, Ewa, et al.
Publicado: (2011)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
por: Łukomska, Alicja, et al.
Publicado: (2021)

Iron and breast cancer risk
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Population Screening for Cancer Family Syndromes in the West Pomeranian Region of Poland
por: Gronwald, Jacek, et al.
Publicado: (2006)

Population Screening of CHEK2 Mutations in Poland
por: Cybulski, Cezary, et al.
Publicado: (2006)

Low-risk Genes and Multi-organ Cancer Risk in the Polish Population
por: Dębniak, Tadeusz, et al.
Publicado: (2006)

The CHEK 2 GENE mutations and the risk of Gastric cancer
por: Teodorczyk, Urszula, et al.
Publicado: (2012)

Nuclear Pedigree Criteria for the Identification of Individuals Suspected to be at Risk of an Inherited Predisposition to Renal Cancer
por: Tołoczko-Grabarek, Aleksandra, et al.
Publicado: (2005)

CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland
por: Jakubowska, Anna, et al.
Publicado: (2010)

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband
por: Gronwald, J, et al.
Publicado: (2009)

Folic acid and cancer risk in BRCA1 carriers
por: Durda, Katarzyna, et al.
Publicado: (2012)

BRCA1 founder mutations compared to ovarian cancer in Belarus
por: Savanevich, Alena, et al.
Publicado: (2014)

Genetic testing for hereditary breast cancer in Poland: 1998–2022
por: Gronwald, Jacek, et al.
Publicado: (2023)

Serum Iron Level and 10-Year Survival after Melanoma
por: Rowińska, Karolina, et al.
Publicado: (2022)

Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population
por: Paszkowska-Szczur, Katarzyna, et al.
Publicado: (2014)

Selenium as a marker of cancer risk and of selection for control examinations in surveillance
por: Lener, Marcin, et al.
Publicado: (2015)

Inherited NBN Mutations and Prostate Cancer Risk and Survival
por: Rusak, Bogna, et al.
Publicado: (2019)

Serum Essential Elements and Survival after Cancer Diagnosis
por: Lubiński, Jan, et al.
Publicado: (2023)

Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population
por: Rogoża-Janiszewska, Emilia, et al.
Publicado: (2020)

Influence of the Levels of Arsenic, Cadmium, Mercury and Lead on Overall Survival in Lung Cancer
por: Pietrzak, Sandra, et al.
Publicado: (2021)

Selenium and cancer risk in CHEK2 mutation carriers
por: Gupta, Satish, et al.
Publicado: (2012)

CHEK2 Mutation in Patient with Multiple Endocrine Glands Tumors. Case Report
por: Szeliga, Anna, et al.
Publicado: (2020)

Serum Selenium Level Predicts 10-Year Survival after Breast Cancer
por: Szwiec, Marek, et al.
Publicado: (2021)

Serum Selenium Level and 10-Year Survival after Melanoma
por: Rogoża-Janiszewska, Emilia, et al.
Publicado: (2021)

DNA testing for variants conferring low or moderate increase in the risk of cancer
por: Kurzawski, Grzegorz, et al.
Publicado: (2008)

Coverage of the Genetic Background of Breast Cancer in the Polish Population
por: Serrano-Fernández, Pablo, et al.
Publicado: (2006)

The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs
por: Lubiński, Jan, et al.
Publicado: (2005)

Founder Mutations for Early Onset Melanoma as Revealed by Whole Exome Sequencing Suggests That This is Not Associated with the Increasing Incidence of Melanoma in Poland
por: Dębniak, Tadeusz, et al.
Publicado: (2019)

Low Blood-As Levels and Selected Genotypes Appears to Be Promising Biomarkers for Occurrence of Colorectal Cancer in Women
por: Baszuk, Piotr, et al.
Publicado: (2021)

Selenium and the risk of cancer of the lung and larynx. A case-control study from a region with low selenium
por: Jaworska, Katrzyna, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bci2q58r8un2c5juqqrkrnai5l